Literature DB >> 21216303

Family friction as ΔNp73 antagonises p73 and p53.

Sarah G Bailey1, Mark S Cragg, Paul A Townsend.   

Abstract

p53 and its homolog p73 are responsible for guarding the genome and regulating cellular responses to genotoxic damage. However, life is never simple and in fact multiple isoforms of each gene exist which may have opposing functions. ΔNp73 is a truncated isoform of p73 which lacks the N-terminal transactivation domain and is up-regulated in a number of diverse primary tumour types. Although its exact cellular function is unclear, upregulation of ΔNp73 has been linked to various pro-tumour activities. Here we review the current literature surrounding this mysterious protein and reveal its potentially important functions in tumourigenesis and treatment resistance.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216303     DOI: 10.1016/j.biocel.2010.12.022

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

Review 1.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

2.  Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

Authors:  Jinhong Wang; Hai Xie; Feng Gao; Tingkun Zhao; Hongming Yang; Bai Kang
Journal:  Tumour Biol       Date:  2015-10-22

Review 3.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

Review 4.  Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Authors:  Brian R Rood; Dominique Leprince
Journal:  Expert Opin Ther Targets       Date:  2013-04-09       Impact factor: 6.902

5.  Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma.

Authors:  Hesham M Hassan; Michelle L Varney; Smrati Jain; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2014-05-06

6.  Modulation of p73 isoforms expression induces anti-proliferative and pro-apoptotic activity in mantle cell lymphoma independent of p53 status.

Authors:  Hesham M Hassan; Michelle L Varney; Nagendra K Chaturvedi; Shantaram S Joshi; Dennis D Weisenburger; Rakesh K Singh; Bhavana J Dave
Journal:  Leuk Lymphoma       Date:  2016-04-13

7.  Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer.

Authors:  G Hofstetter; A Berger; E Schuster; A Wolf; G Hager; I Vergote; I Cadron; J Sehouli; E I Braicu; S Mahner; P Speiser; C Marth; A G Zeimet; H Ulmer; R Zeillinger; N Concin
Journal:  Br J Cancer       Date:  2011-10-18       Impact factor: 7.640

Review 8.  p53 Family and Cellular Stress Responses in Cancer.

Authors:  Johanna Pflaum; Sophie Schlosser; Martina Müller
Journal:  Front Oncol       Date:  2014-10-21       Impact factor: 6.244

9.  TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics.

Authors:  Johanna Rodhe; Edel Kavanagh; Bertrand Joseph
Journal:  Oncotarget       Date:  2013-02

10.  Role of p73 Dinucleotide Polymorphism in Prostate Cancer and p73 Protein Isoform Balance.

Authors:  L Michael Carastro; Hui-Yi Lin; Hyun Y Park; Donghwa Kim; Selina Radlein; Kaia K Hampton; Ardeshir Hakam; Babu Zachariah; Julio Pow-Sang; Jong Y Park
Journal:  Prostate Cancer       Date:  2014-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.